NSC |
Compound |
Enrichment |
Correlation |
NSC 749160 |
Null |
0.0295480456086945 |
0.30160185 |
NSC 751830 |
2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one |
0.0295480456086945 |
0.050185433 |
NSC 753376 |
3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1-methyl-1H-indole |
0.0295480456086945 |
0.28290449 |
NSC 102051 |
Null |
0.0295480456086947 |
-0.050585489 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.12591229 |
NSC 15795 |
Null |
0.0295480456086947 |
0.1720174 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0295480456086947 |
0.50682484 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0295480456086947 |
0.35934729 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0295480456086947 |
0.15608093 |
NSC 208885 |
Null |
0.0295480456086947 |
0.090469532 |